Brand News Bonafide® Health Launches Thermella™, The First and Only Hormone-Free, Prescription-Free… Thermella, a neurokinin 3 receptor (NK3R) antagonist, relieves symptoms at the source in as early as two weeks by rebalancing…
Science & Quality Bonafide Health Issues Findings of 4th Annual State of Menopause… Differing Attitudes of Millennials and Gen X Signal Powerful Shift in Approach to Menopause Management, Women Consider Using Their Vote…
Brand News Pharmavite Announces $425 Million Acquisition of Bonafide Health to Become… Pharmavite’s Brand Portfolio Now Includes Bonafide®, Uqora®, and Equelle®, Cementing the Health and Wellness Pioneer as the Market Leader in…
Science & Quality Bonafide Health’s 3rd Annual ‘State of Menopause’ Survey Reveals Startling… 69% of Women Don’t Recognize the Initial Symptoms of Menopause and 79% Say the Best Way to Navigate Menopause is…